This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
November 11, 2019
Presentation of ONCOS-102 melanoma data at SITC Annual Meeting
November 11, 2019
GOLD’s evidence “A” rating affirms that endobronchial valves, like the Zephyr Valve, are a proven, viable, minimally-invasive treatment option for severe emphysema, a form of COPD
November 08, 2019
Orexo to Present at Jefferies 2019 Healthcare Conference
November 08, 2019
Interim report January-September 2019
November 07, 2019
Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 07, 2019
BONESUPPORT HOLDING AB (publ) – Publishes Q3 2019 Interim report
November 07, 2019
Targovax ASA: Third quarter 2019 results
November 06, 2019
Aprea Therapeutics to Present Data from U.S. Phase 1b/2 MDS/AML Trial and French Phase 1b/2 MDS/AML Trial at 61st American Society of Hematology Annual Meeting
November 06, 2019
Oncopeptides to Highlight Data from Melflufen Clinical Program in Multiple Myeloma and AL Amyloidosis in Six Presentations at ASH Annual Meeting 2019
November 05, 2019
Strongbridge Biopharma plc Announces CEO Transition Plan and Provides Preliminary Third Quarter 2019 Financial Results and Corporate Updates